Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Cancer drugs which target the effects of abnormal gene changes are called 'targeted
therapies'. This study, called PM.1 or CAPTUR, will include some targeted therapies that are
currently available. The purpose of this study is to find out what are the effects on a
patient and their cancer when they are given a targeted therapy drug that is specific to an
abnormal gene change in their cancer.